Cite this post as:
Scott Weingart, MD FCCM. EMCrit RACC Wee – Debate re: Idarucizumab with @First10em. EMCrit Blog. Published on April 5, 2018. Accessed on May 22nd 2022. Available at [https://emcrit.org/emcrit/debate-re-idarucizimab/ ].
Dr. Scott Weingart, Course Director, reports no relevant financial relationships with ineligible companies.
This episode’s speaker(s), (listed above), report no relevant financial relationships with ineligible companies.
Original Release: April 5, 2018
Date of Most Recent Review: Jan 1, 2022
Termination Date: Jan 1, 2025
You finished the 'cast,
Now Join EMCrit!
As a member, you can...
- Get CME hours
- Get the On Deeper Reflection Podcast
- Support the show
- Write it off on your taxes or get reimbursed by your department
Get the EMCrit Newsletter
If you enjoyed this post, you will almost certainly enjoy our others. Subscribe to our email list to keep informed on all of the Resuscitation and Critical Care goodness.
This Post was by the EMCrit Crew, published 4 years ago. We never spam; we hate spammers! Spammers probably work for the Joint Commission.